Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Investing Activities (2016 - 2022)

Historic Cash from Investing Activities for Nephros (NEPH) over the last 9 years, with Q2 2022 value amounting to -$103000.0.

  • Nephros' Cash from Investing Activities changed N/A to -$103000.0 in Q2 2022 from the same period last year, while for Sep 2024 it was -$103000.0, marking a year-over-year change of. This contributed to the annual value of -$50000.0 for FY2024, which is 3333.33% up from last year.
  • Latest data reveals that Nephros reported Cash from Investing Activities of -$103000.0 as of Q2 2022.
  • In the past 5 years, Nephros' Cash from Investing Activities ranged from a high of -$13000.0 in Q3 2020 and a low of -$137000.0 during Q1 2019
  • Over the past 4 years, Nephros' median Cash from Investing Activities value was -$34000.0 (recorded in 2022), while the average stood at -$55142.9.
  • In the last 5 years, Nephros' Cash from Investing Activities skyrocketed by 714.29% in 2020 and then crashed by 37692.31% in 2021.
  • Over the past 4 years, Nephros' Cash from Investing Activities (Quarter) stood at -$14000.0 in 2019, then increased by 7.14% to -$13000.0 in 2020, then crashed by 376.92% to -$62000.0 in 2021, then plummeted by 66.13% to -$103000.0 in 2022.
  • Its Cash from Investing Activities stands at -$103000.0 for Q2 2022, versus -$34000.0 for Q1 2022 and -$62000.0 for Q3 2021.